Batelapine

Batelapine
Clinical data
Other namesCGS-13429
Routes of
administration		By mouth
ATC code
  • None
Pharmacokinetic data
Elimination half-life8.1 Hours
Identifiers
  • 2-methyl-5-(4-methylpiperazin-1-yl)-11H-[1,2,4]triazolo[1,5-c][1,3]benzodiazepine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H20N6
Molar mass296.378 g·mol−1
3D model (JSmol)
  • CC1=NN2C(=N1)CC3=CC=CC=C3N=C2N4CCN(CC4)C
  • InChI=1S/C16H20N6/c1-12-17-15-11-13-5-3-4-6-14(13)18-16(22(15)19-12)21-9-7-20(2)8-10-21/h3-6H,7-11H2,1-2H3 checkY
  • Key:PUHMYHQVPODHCZ-UHFFFAOYSA-N checkY

Batelapine (developmental code name CGS-13429) is a structural analogue of clozapine which was investigated as a potential antipsychotic.[1][2]

References

  1. ^ Chovan JP, Vermeulen JD (September 1989). "High-performance liquid chromatographic method for a clozapine analogue, CGS 13429, and its N-oxide and desmethyl metabolites". Journal of Chromatography. 494: 413–9. doi:10.1016/s0378-4347(00)82697-3. PMID 2573611.
  2. ^ "Batelapine - AdisInsight".



This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.